The life science industry sector: Evolution of agro-biotechnology in Europe

Joanna Chataway and David Wield

Science and Public Policy, 2002, vol. 29, issue 4, 253-258

Abstract: This article reports on a detailed study of large agro-biotechnology companies, conducted during the recent period of rapid industrial restructuring. The concept of life science synergy, involving a useful cross-fertilisation of ideas between the development of new drugs and new crop protection products, has floundered. Although negative public reaction to GM (genetically modified) crop development is a significant cause, our research suggests that there are other more subtle causes, such as organisational culture differences between agro-chemicals and biotechnology disciplines and between seeds and chemicals firms. We found three distinct approaches to life science and technology trajectory-seeking in top agro-biotechnology companies. Copyright , Beech Tree Publishing.

Date: 2002
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://hdl.handle.net/10.3152/147154302781780949 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:29:y:2002:i:4:p:253-258

Access Statistics for this article

Science and Public Policy is currently edited by Nicoletta Corrocher, Jeong-Dong Lee, Mireille Matt and Nicholas Vonortas

More articles in Science and Public Policy from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().